# Mereo BioPharma Group plc: Form 8-K, filed Jan 13, 2025

- Company: [Mereo BioPharma Group plc](/companies/mreo.md) (CIK 1719714)
- Form: 8-K
- Filed: 2025-01-13
- Accepted by EDGAR: Jan 13, 2025, 06:32 ET
- Period: 2025-01-12
- Accession: 0000950170-25-004523
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1719714/000095017025004523/mreo-20250112.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1719714/000095017025004523/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1719714/000095017025004523/mreo-20250112.htm

Filed Jan 13, 2025.
Source: SEC EDGAR, the filing index for accession 0000950170-25-004523. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.